Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
BRADYARRHYTHMIAS IN PATIENTS WITH CRYPTOGENETIC STROKE IMPLANTED WITH LOOP RECORDER
Anno:
2025
Implantable loop recorder (ILR) can be used to detect subclinical atrial fibrillation (AF) in patients with embolic stroke of undetermined origin (ESUS). In literature the incidence of AF is about 18% with a risk of recurrence of stroke in antiplatelet therapy of 4.5%. ESUS is a severely disabling stroke with high mortality rate.To improve the…
Leggi di più
HEALTH LITERACY AND ITS IMPACT ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE COHORT STUDY
Anno:
2025
Background: Health literacy (HL) is a risk factor for clinical outcomes in patients with cardiovascular diseases. This study explored HL levels and their impact, alongside clinical and nursing factors, on mortality, hospital readmissions, and emergency department (ED) visits in patients with atrial fibrillation. Methods: A prospective cohort study was…
Leggi di più
CARDIAC IMPLANTABLE DEVICES IN A PEDIATRIC POPULATION WITH LEFT VENTRICULAR HYPERTRABECULATION: A SINGLE CENTRE EXPERIENCE
Anno:
2025
Left Ventricular Hypertrabeculation (LVHT) is a myocardial disorder characterized by abnormal trabeculations in the left ventricular lumen and deep intertrabecular recesses; this phenotypic trait can occur either in isolation or in association with other conditions, such as left ventricular hypertrophy, dilation, systolic/diastolic dysfunction or congenital heart defects. In recent…
Leggi di più
EFFECTIVENESS OF PERCUTANEOUS STELLATE GANGLION BLOCKADE IN THE TREATMENT OF ARRHYTHMIC STORM. ROLE OF THE UNDERLYING HEART DISEASE.
Anno:
2025
Introduction   The sympathetic nervous system plays a crucial role in the genesis and maintenance of ventricular arrhythmias, which are frequently observed in patients with various types of heart disease. Percutaneous stellate ganglion blockade (PSGB) has been shown to be an effective and safe treatment for managing arrhythmic storm….
Leggi di più
Atrial Fibrillation Treatment: Efficacy of Early vs. Delayed Catheter Ablation. A Meta-Analysis Based on Observational Studies.
Anno:
2025
Background: The optimal timing for catheter ablation (CA) in patients with atrial fibrillation (AF) remains uncertain. Objective: This study aims to evaluate whether early catheter ablation (within 1 year of diagnosis) compared to delayed catheter ablation (≥1 year) is associated with a lower rate of arrhythmia recurrence. Methods: Following…
Leggi di più
CARDIONEUROABLATION IN A YOUNG PATIENT WITH THIRD-DEGREE ATRIOVENTRICULAR BLOCK
Anno:
2025
Introduction: Cardioneuroablation (CNA) is a transcatheter ablation technique targeting atrial parasympathetic ganglia to reduce vagal response in conditions like vaso-vagal syncope and functional atrioventricular block (AVB). Differentiating between vagal hypertonia and intrinsic conduction system damage is essential before considering CNA. In cases of intermittent bradycardia and AVB that improve…
Leggi di più
Catheter Ablation of Premature Ventricular Beats Originating from Left Ventricular Summit in a Patient with Primary Dilated Cardiomyopathy
Anno:
2025
Introduction Premature ventricular contractions (PVCs) are frequently benign. However, a high arrhythmic burden can lead to the deterioration of left ventricular systolic function, resulting in newly developed cardiomyopathy or worsening of pre-existing cardiopathy. 2022 ESC guidelines for the management of ventricular arrhythmias recommend catheter ablation as class I treatment…
Leggi di più
Wearable cardioverter defibrillator in patient with transient risk of sudden cardiac death : single centre experience
Anno:
2025
Background Worldwide sudden cardiac death (SCD) remains a major cause of death, despite the recent progress in prevention and interventions of cardiac disease. Implantable  cardioverter defibrillator (ICD) is an effective weapon for SCD prevention in high risk patients with reasonable expectation of survival.However in case of transient  risk of SCD, the…
Leggi di più
Atrial Cardiomiopathy is caused by bone marrow dysfunction via folate cycle disorders and dyserythropoiesis
Anno:
2025
Background: It is accepted that Atrial Fibrillation (AF) does not explain the wholeness of embolic strokes, this forcing postulation of a broader Atrial Cardiomyopathy (AC) entity. Left atrial fibrosis (Fib) is the marker of AC but its pathogenesis is not focused. Folate cycle disorders (FCD) are a dysmetabolism partly…
Leggi di più
DEEP SEDATION WITH ONLY PROPOFOL FOR ELECTIVE EXTERNAL ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: EXPERIENCE AND SAFETY OF AN CARDIOLOGICAL PROCEDURAL MANAGEMENT
Anno:
2025
Worldwide, atrial fibrillation is the most common sustained cardiac arrhythmia in adults. Electrical cardioversion is still the preferred method to restore sinus rhythm in patients with atrial fibrillation. The main, and probably the only, disadvantage of electrical cardioversion is that it requires deep sedation with anesthetics. The most widely…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram